Novel Stem Cell-Derived Islet Cell Therapy Continues to Show Promise for Achieving Insulin Independence for Individuals with Type 1 Diabetes

Stem Cell-Derived Fully Differentiated Islet Cells Shown to Restore Endogenous Insulin Secretion and Improved Glycemic Control in People Living with Type 1 Diabetes SAN DIEGO, June 23, 2023 /PRNewswire/ — Today, findings from the ongoing clinical trial of VX-880, a phase 1/2,…